Asia Pacific bioprocess technology market will grow by 15.0% annually with a total addressable market cap of $170.71 billion over 2024-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology sector, ongoing technological advancements, and a rising number of new drug production and launches.
Highlighted with 36 tables and 60 figures, this 133-page report "Asia Pacific Bioprocess Technology Market 2023-2033 by Product (Instruments, Consumables and Accessories), Process (Upstream, Downstream), Procedure, Application (Recombinant Proteins, Antibiotics, Biosimilars, mAbs, Others), End User (Biopharma Companies, CMOs, Institutes, CROs), and Country: Trend Forecast and Growth Opportunity" is based on comprehensive research of the entire Asia Pacific bioprocess technology market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2021-2023 and provides a forecast from 2024 till 2033 with 2023 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter's Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific bioprocess technology market in every aspect of the classification from perspectives of Product, Process, Procedure, Application, End User, and Country.
Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
• Instruments
o Bioprocess Analyzers
o Osmometers
o Bioreactors
o Incubators
o Other Instruments
• Consumables and Accessories
o Culture Media
o Reagents
o Other Consumables and Accessories
Based on Process, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
• Upstream Bioprocessing
• Downstream Bioprocessing
By Procedure, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
• Cell Culture
• Cell Expansion
• Flow Cytometry
• Cell Line Development
• Cell Counting
• Biologics Safety Testing
• Tangential Flow Filtration (TFF)
• Other Procedures
By Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
• Recombinant Proteins
• Antibiotics
• Biosimilars
• Monoclonal Antibodies (mAbs)
• Other Applications
By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.
• Biopharmaceutical Companies
• Contract Manufacturing Organizations (CMOs)
• Academic Research Institutes
• Contract Research Organizations (CROs)
• Food & Feed Industry
• Other End Users
Geographically, the following national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2023-2033. The breakdown of national markets by Product, Application, and End User over the forecast years are also included.
The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Advanced Instruments LLC
Agilent Technologies, Inc.
Becton Dickinson and Company
Bio-rad Laboratories Inc.
Boehringer Ingelheim International GmbH
Catalent Inc.
Charles River Laboratories
Corning Inc.
Danaher Corporation
Elitechgroup Inc. (gonotec Gmbh)
Eppendorf Se
F. Hoffmann-la Roche Ltd.
Fujifilm Healthcare Americas Corporation
GE Healthcare (General Electric Company)
Getinge Ab
Koninklijke Philips N.V.
Lonza Group Ag
Merck Kgaa
Repligen Corp.
Sartorius Group
STADA Arzneimittel AG
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 24
2.1.3 Impact of Russia-Ukraine Conflict 26
2.1.4 Impact of Israel-Palestine War 28
2.2 Major Growth Drivers 29
2.3 Market Restraints and Challenges 34
2.4 Emerging Opportunities and Market Trends 37
2.5 Porter's Fiver Forces Analysis 41
3 Segmentation of Asia Pacific Market by Product 45
3.1 Market Overview by Product 45
3.2 Instruments 47
3.2.1 Bioprocess Analyzers 49
3.2.2 Osmometers 50
3.2.3 Bioreactors 51
3.2.4 Incubators 52
3.2.5 Other Instruments 53
3.3 Consumables and Accessories 54
3.3.1 Culture Media 56
3.3.2 Reagents 57
3.3.3 Other Consumables and Accessories 58
4 Segmentation of Asia Pacific Market by Process 59
4.1 Market Overview by Process 59
4.2 Upstream Bioprocessing 61
4.3 Downstream Bioprocessing 62
5 Segmentation of Asia Pacific Market by Procedure 63
5.1 Market Overview by Procedure 63
5.2 Cell Culture 65
5.3 Cell Expansion 66
5.4 Flow Cytometry 67
5.5 Cell Line Development 68
5.6 Cell Counting 69
5.7 Biologics Safety Testing 70
5.8 Tangential Flow Filtration (TFF) 71
5.9 Other Procedures 72
6 Segmentation of Asia Pacific Market by Application 73
6.1 Market Overview by Application 73
6.2 Recombinant Proteins 75
6.3 Antibiotics 76
6.4 Biosimilars 77
6.5 Monoclonal Antibodies (mAbs) 78
6.6 Other Applications 79
7 Segmentation of Asia Pacific Market by End User 80
7.1 Market Overview by End User 80
7.2 Biopharmaceutical Companies 82
7.3 Contract Manufacturing Organizations (CMOs) 83
7.4 Academic Research Institutes 84
7.5 Contract Research Organizations (CROs) 85
7.6 Food & Feed Industry 86
7.7 Other End Users 87
8 Asia-Pacific Market 2023-2033 by Country 88
8.1 Overview of Asia-Pacific Market 88
8.2 Japan 91
8.3 China 94
8.4 Australia 97
8.5 India 99
8.6 South Korea 101
8.7 Rest of APAC Region 103
9 Competitive Landscape 105
9.1 Overview of Key Vendors 105
9.2 New Product Launch, Partnership, Investment, and M&A 109
9.3 Company Profiles 110
Advanced Instruments LLC 110
Agilent Technologies, Inc. 112
Becton Dickinson and Company 113
Bio-rad Laboratories Inc. 114
Boehringer Ingelheim International GmbH 115
Catalent Inc. 116
Charles River Laboratories 117
Corning Inc. 118
Danaher Corporation 119
Elitechgroup Inc. (gonotec Gmbh) 120
Eppendorf Se 121
F. Hoffmann-la Roche Ltd. 122
Fujifilm Healthcare Americas Corporation 123
GE Healthcare (General Electric Company) 124
Getinge Ab 125
Koninklijke Philips N.V. 126
Lonza Group Ag 127
Merck Kgaa 128
Repligen Corp. 129
Sartorius Group 130
STADA Arzneimittel AG 131
Thermo Fisher Scientific Inc. 132
RELATED REPORTS 133
The Restaurant Technology Solutions Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, man...
The Distributed Renewable Energy Generation Technology Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competi...
The Advertising Technology Service Solutions Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lands...
The Palm Vein Recognition Technology Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ma...
The Molded Interconnect Substrate Technology Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lands...
The Speech Synthesis Technology Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufac...
The Industrial Methanation Technology Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...
Market Overview
The Asia Pacific Vanadium Market is poised for substantial growth from 2024 to 2034, driven by increasing demand across various industries and technological advancements in vanadium production. The market is projected to reach USD XX.XX billion by 2034, growing at a comp...
Market Overview
The Asia Pacific Vascular Closure Devices Market is anticipated to experience substantial growth from 2024 to 2034. The market's expansion is fueled by advancements in vascular closure technologies, increasing prevalence of cardiovascular diseases, and the growing adopti...
Market Overview
The Asia Pacific Nuclear Medicine Market is poised for significant growth from 2024 to 2034, driven by advancements in nuclear imaging technologies, increased application in various medical fields, and rising healthcare investments across the region. The market is expect...